Traws Pharma, Inc. TRAW
0.30 USD +0.01 +1.76%
As of Nov 2, 1:09 PM ET
- YTD
- -73.35%
- 1 year
- -88.28%
- Open
- 0.3004
- Prev close
- 0.296
- Mkt cap
- 4.63M
- Vol
- 45.65K
- Avg vol
- 584.83K
- EPS
- -1.71
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.299
- High
- 0.31
- Forward P/E
- -0.47
- Beta
- 1.41
- Short ratio
- 0.62
- Inst. own
- 21.40%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 4.96
- 200-d avg
- 11.13
- 1y target
- 6.00
MAX chart
Chart tools
Chart is warming up
The all-time price history for TRAW has not been loaded yet. Try again in a moment.
Altman Z-Score
-117.77 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B-2 / 5 overall
- DCF 5
- Return on Equity 5
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
P/E 1.4×
P/S 3.3×
P/B -14.8×
P/FCF -0.4×
EV/EBITDA -0.3×
EV/Sales 2.0×
FCF Yield -223.4%
Gross Margin 100.0%
Operating Margin -640.7%
Net Margin 328.7%
ROE -1457.9%
ROIC 3379.0%
ROA 86.4%
Revenue 1134.5%
Operating Income 63.8%
EPS (diluted) 102.3%
Free Cash Flow 30.3%
Current Ratio 0.7×
Quick Ratio 0.7×
Debt / Equity 0.0×
Net Debt / EBITDA 0.2×
Interest Coverage 0.0×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31